Fervo Energy Company Class A common stock
FRVO
$11.38
0Fervo Energy is a geothermal energy developer that builds, owns, and operates enhanced geothermal power facilities, generating revenue primarily through long-term power purchase agreements (PPAs) with utilities and other offtakers, and it differentiates itself from conventional geothermal players by applying oil-and-gas techniques such as horizontal drilling, computational reservoir modeling, and distributed fiber optic sensing to unlock power from hot dry rock. The company sits at the intersection of the renewable utilities sector and the emerging 'next-generation geothermal' theme, positioning itself as a technology-enabled first mover rather than a traditional rate-base utility, with a project pipeline aimed at supplying firm, dispatchable clean power to data centers and grid operators. The investor narrative is dominated by a violent post-IPO de-rating: after listing on Nasdaq in May 2026, the stock has collapsed from the high-$30s to roughly $11, erasing the majority of its value as investors digest the capital intensity of its buildout, minimal current revenue against heavy spending, and a broad risk-off backdrop for pre-revenue energy transition names. Against that, sell-side coverage remains uniformly constructive, and the most recent session featured a sharp double-digit rebound, suggesting a debate now centered on whether the selloff has overshot the long-term contracted cash flow potential of its geothermal fleet.…
FRVO
Fervo Energy Company Class A common stock
$11.38
Related headlines
People also watch
Brookfield Renewable
BEPC
Ormat Technologies
ORA
Clearway Energy, Inc. Class C Common Stock
CWEN
Duke Energy Corporation Corporate Units
DUKU
NextEra Energy
NEE
Investment Opinion: Should I buy FRVO Today?
Rating: Hold (speculative, high-risk). The core thesis is that Fervo's differentiated enhanced-geothermal technology and contracted PPA pipeline could support a multi-hundred-million-dollar revenue business, but at $11.38 the equity is priced for execution that has not yet appeared in reported results — Q2 2026 revenue was just $113,000 against a $7.66 billion market cap — while the unanimous strong_buy consensus (15 Buys, 0 Holds, 0 Sells) and $34.07 average target imply +199% upside that appears anchored to pre-collapse prices rather than marked to the new reality.
Supporting evidence cuts both ways. On the positive side, the $2.106 billion cash balance (up from $280.78 million after a $2.05 billion issuance) and a current ratio of 3.17 fund the drilling program through 2027, the forward sales multiple of roughly 9.8x on consensus revenue of ~$777.7 million is not extreme for a technology-differentiated platform, and even the $16.00 low analyst target implies +41% upside. Against that, gross margin is -3.91%, operating margin is -353.67%, Q2 free cash flow was -$261.22 million versus -$181.83 million in Q1, H1 burn totaled roughly $443 million, and the stock is down 68.86% over six months at just 10.7% of its 52-week range — a falling-knife profile with relative strength of -50.60% versus the S&P over three months.
The biggest risks that could invalidate the thesis are (1) another equity raise into a falling stock that forces analyst targets down toward the $16 low or below, (2) a revenue ramp that slips again, leaving the forward sales multiple unsupported, and (3) a decisive break below the $7.64 52-week low that triggers fresh distribution. This Hold would upgrade to Buy if a quarterly print shows revenue inflecting toward the consensus ramp with gross margin turning positive, or if the stock reclaims the $14-16 resistance shelf on volume; it would downgrade to Sell if revenue stays near zero while burn accelerates or if the company announces a dilutive raise below $10. On balance the stock is deeply undervalued relative to its own short public history and analyst targets, but fairly-to-richly valued relative to what current fundamentals justify — a speculative position, not a core holding.
Sign up to view all
FRVO 12-Month Price Forecast
Fervo is a high-risk, high-reward speculative name where the bear case currently has stronger evidence — a -81.67% max drawdown, negative gross margin, and accelerating cash burn — but the bull case is not without merit given a funded balance sheet, differentiated technology, and a unanimous Street that models no downside from $11.38. The valuation is bifurcated: trailing multiples are meaningless (PS of 55,479x on a near-zero denominator), while the ~9.8x forward sales multiple is defensible only if the multi-hundred-fold revenue ramp materializes. The single most important variable is whether the next quarterly print shows a real top-line inflection before the next capital raise; if it does, the stale targets become credible and the stock could re-rate toward the mid-teens to $20s, but if revenue stays near zero while burn accelerates, targets will be cut and the stock re-tests the $7.64 low. I would upgrade to bullish on a confirmed revenue inflection with positive gross margin or a reclaim of the $14-16 resistance shelf, and downgrade to bearish on a dilutive raise below $10 or a decisive break of $7.64.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fervo Energy Company Class A common stock's 12-month outlook, with a consensus price target around $32.40 and implied upside of +184.7% versus the current price.
Average Target
$32.40
16 analysts
Implied Upside
+184.7%
vs. current price
Analyst Count
16
covering this stock
Price Range
$16 - $51
Analyst target range
Coverage is robust for a recent IPO, with 14 analysts contributing to a consensus that is unanimously bullish: 15 Buy ratings, zero Holds, and zero Sells, producing a recommendation of 'strong_buy' and a recommendation mean of 1.33. The average target price of $34.07 implies roughly +199% upside from the current $11.38, a spread so wide relative to the share price that it signals the targets were largely set before or during the collapse and have not been marked down to reflect the new reality. The consensus clearly leans aggressively bullish, and the divergence between a 'strong_buy' rating and a stock trading at 10.7% of its 52-week range is the central tension in the name — either the Street sees a mispriced long-term compounder or the estimates are stale. The target range runs from a low of $16.00 to a high of $51.00, a 3.2x spread that underscores very high uncertainty; even the low target implies about +41% upside from $11.38, meaning no analyst models downside from here, which itself is a warning sign of anchoring. The high target of $51 likely assumes successful execution across the project pipeline, multiple expansion on contracted cash flows, and the data-center-driven demand narrative fully materializing, while the $16 low case probably embeds slower capacity additions, continued capital raises, and margin compression before scale is reached. Institutional actions skew positive but are mostly reiterations rather than fresh upgrades: Wolfe Research upgraded to Outperform from Peer Perform on September 25, Jefferies moved to Buy from Hold on July 20, and B of A Securities upgraded to Buy from Neutral on July 17, while JP Morgan, Bernstein, Barclays, RBC, and Baird have maintained Outperform/Overweight/Buy ratings through October. The pattern of upgrades clustered in July and September, followed by reiterations into October as the stock kept falling, suggests analysts are defending long-term theses while the market votes otherwise — a setup where a wide target spread and heavy short interest (short ratio 2.84) make violent squeezes like the +26.09% session on November 9 plausible, but also where estimate cuts remain a live risk if the next quarterly print does not show revenue inflection.
Drowning in data?
Find the real signal!
Bulls vs Bears: FRVO Investment Factors
The bear case currently has stronger evidence: the stock is down 68.86% in six months, trades at 10.7% of its 52-week range, generates only $113,000 of quarterly revenue at a negative gross margin, and burned roughly $443 million of free cash flow in H1 2026. The bull case rests almost entirely on forward expectations — a consensus revenue estimate of ~$777.7 million, a unanimous strong_buy rating, and an average target of $34.07 that implies +199% upside — but those targets appear anchored to pre-collapse prices rather than marked to the new reality. The single most important tension is whether the contracted PPA pipeline and data-center demand can convert into a visible revenue inflection before the next capital raise; if the next quarterly print shows real top-line ramp, the 9.8x forward sales multiple looks defensible, but if revenue stays near zero while burn accelerates, the stale targets will be cut and the stock re-rates lower. Until that inflection appears, the market is pricing execution skepticism, and the burden of proof sits with the company.
Bullish
- Unanimous Street support, no sell ratings: All 15 ratings are Buy with zero Holds and zero Sells, a recommendation mean of 1.33, and 14 analysts covering a stock that listed only in May 2026. Even the lowest target of $16.00 implies +41% upside from $11.38, meaning no analyst models downside from here.
- Massive implied upside to consensus target: The average target of $34.07 sits roughly +199% above the current $11.38 price, and the high target of $51.00 implies about +348%. The 3.2x spread between the $16 low and $51 high shows wide disagreement, but the entire distribution is above the current quote.
- Forward revenue ramp implies reasonable forward sales multiple: Consensus revenue of ~$777.7 million against a $7.66 billion market cap yields roughly 9.8x forward sales, a premium to regulated renewable developers but not extreme for a technology-differentiated geothermal platform with contracted offtake. Consensus EPS of $0.633 implies the market expects a step-function revenue inflection from the current $113,000 quarterly base.
- Liquidity runway funded through 2027 buildout: A $2.05 billion common stock issuance lifted cash to $2.106 billion from $280.78 million, with a current ratio of 3.17 and a Q2 cash ratio of 8.42. Against H1 free cash burn of roughly $443 million, that balance sheet funds the drilling program without immediate financing pressure.
Bearish
- Catastrophic post-IPO de-rating: The stock has fallen from a $42.65 52-week high to $11.38, a max drawdown of -81.67%, and sits at just 10.7% of its 52-week range. It is down 68.86% over six months and 52.92% over three months, with relative strength versus the S&P 500 at -50.60% over three months while SPY fell only 2.32%.
- Pre-revenue economics with negative gross margin: Q2 2026 revenue was just $113,000 against cost of revenue of $650,000, producing gross profit of -$537,000 and a gross margin of -3.91%. The company loses money on every dollar of electricity sold, and trailing price-to-sales of 55,479x is economically meaningless given the near-zero denominator.
- Accelerating cash burn and permanent dilution risk: Q2 free cash flow was -$261.22 million versus -$181.83 million in Q1, on capex of -$226.49 million, and H1 burn totaled roughly $443 million. Net loss widened to -$59.53 million in Q2 from -$35.26 million in Q1, with operating margin of -353.67%, so the equity story depends on repeatedly tapping capital markets.
- Analyst targets look stale and anchored: The $34.07 average target implies +199% upside, a spread so wide it signals targets were set before or during the collapse and not marked down. Upgrades clustered in July (B of A, Jefferies) and September (Wolfe) followed by October reiterations as the stock kept falling suggest analysts are defending theses while the market votes otherwise.
FRVO Technical Analysis
The prevailing trend is an unambiguous, sustained downtrend: the stock is down 68.86% over six months and 52.92% over three months, and at $11.38 it sits at just 10.7% of its 52-week range of $7.64 to $42.65 (a range span of $35.01). That positioning near the absolute bottom of the range signals a falling-knife profile rather than a value opportunity, with the maximum drawdown from the post-IPO peak reaching -81.67%, indicating that buyers have been repeatedly overwhelmed and that overhead supply is heavy at every prior price shelf. The one-year change is technically positive at +2.355%, but this is a meaningless artifact of the May 2026 IPO base price rather than evidence of trend strength. Recent momentum shows tentative stabilization rather than reversal: the 1-month change is -17.24%, a marked deceleration from the -52.92% three-month decline, and the latest session ripped +26.09% from a $9.025 previous close to $11.38 on elevated volume of roughly 23.96 million shares. That single-day surge, coming after a capitulation low near $7.79 on November 5, looks like a short-covering and oversold bounce, and it still leaves the stock deeply below where it traded a month ago; relative strength versus the S&P 500 is -13.92% over one month and -50.60% over three months, confirming severe underperformance even as SPY fell only 3.32% and 2.32% over those same windows. Key levels are clean: support rests at the $7.64 52-week low, with the $7.79-8.25 congestion zone from late October/early November as the immediate floor, while resistance begins at the $12.87-14.46 shelf from early October and extends to the $16.92-19.75 band from August/September. A decisive break below $7.64 would signal a fresh leg of distribution and likely force a re-rating of the IPO cohort, whereas reclaiming $14 would be the first evidence of a durable bottom and put the $20 area in play. No beta is provided, but the -81.67% drawdown, 26% single-day move, and 2.84 short ratio collectively describe a high-volatility, heavily shorted name where position sizing must assume gap risk in both directions.
Beta
—
—
Max Drawdown
-81.7%
Largest decline past year
52-Week Range
$8-$43
Price range past year
Annual Return
—
Cumulative gain past year
| Period | FRVO Return | S&P 500 |
|---|---|---|
| 1m | -17.2% | -3.7% |
| 3m | -43.6% | -2.9% |
| 6m | -72.0% | +0.2% |
| 1y | — | +10.1% |
| ytd | — | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FRVO Fundamental Analysis
The revenue trajectory is effectively pre-commercial: Q2 2026 revenue was just $113,000, up from $61,000 in Q1 2026, a roughly 85% sequential increase off a negligible base, while gross profit was -$537,000 against cost of revenue of $650,000, meaning the company currently loses money on every dollar of electricity it sells. There is no segment disclosure to parse, and the scale of revenue is so small relative to the $7.66 billion market cap that the investment case rests entirely on future capacity additions and PPA signings rather than current top-line momentum; the sell-side consensus revenue estimate of approximately $777.7 million (range $612.8 million to $860.6 million) implies the market expects a step-function ramp that has not yet appeared in reported results. Profitability is deeply negative and worsening in absolute terms: Q2 2026 net income was -$59.53 million versus -$35.26 million in Q1, with EBITDA of -$28.40 million versus -$19.96 million, operating margin of -353.67%, net margin of -510.98%, and gross margin of -3.91%. The deterioration is driven less by gross-level economics than by overhead — SG&A of $28.92 million in Q2 plus $27.17 million of net other expenses and $2.22 million of interest expense — and the reported ROE of +28.61% is a distortion from a small or negative equity base rather than genuine profitability, while the -$0.0092 EPS figure conflicts with the -$0.20 quarterly diluted EPS and should be treated with caution. Balance sheet and cash flow tell the real story: Q2 free cash flow was -$261.22 million (versus -$181.83 million in Q1) on capital expenditure of -$226.49 million, operating cash flow of -$34.74 million, and a $2.05 billion common stock issuance that lifted cash to $2.106 billion from $280.78 million at the start of the period. The current ratio of 3.17 and Q2 cash ratio of 8.42 indicate ample near-term liquidity, and the reported debt-to-equity of -1.015 is a negative-equity artifact rather than a leverage signal, but the company is unambiguously dependent on external financing — it burned roughly $443 million of free cash flow across the first half and must keep tapping capital markets to fund its drilling program, making dilution risk a permanent feature of the equity story.
Quarterly Revenue
$113000.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FRVO Overvalued?
Because net income is negative (-$59.53 million in Q2 2026) and EBITDA is also negative (-$28.40 million), neither the PE nor the EV/EBITDA multiple is meaningful; the trailing PE of -108 and EV/EBITDA of -153.45 are sign artifacts, so the appropriate primary metric is price-to-sales, which at 55,479x on trailing revenue is economically meaningless given the $113,000 quarterly base. The more informative lens is the forward picture: the forward PE of -35.53 against consensus EPS of $0.633 and consensus revenue of roughly $777.7 million implies the market is capitalizing a business that has essentially no current sales but is expected to scale dramatically, and the enormous gap between trailing and forward figures reflects expectation of a multi-hundred-fold revenue ramp rather than any near-term earnings power. Peer comparison is not credible on trailing multiples — a PS of 55,479x versus any renewable utilities benchmark is a function of a near-zero denominator, not a premium — but on a forward basis, applying the $7.66 billion market cap to $777.7 million of estimated revenue yields roughly 9.8x forward sales, which is a premium to typical regulated renewable developers but not extreme for a growth-stage, technology-differentiated geothermal platform with contracted offtake. The negative book value (PB of -31.06) and negative price-to-cash-flow (-241.09) further confirm that book- and cash-based anchors are unusable, leaving forward sales and project-level NAV as the only defensible frameworks. Historical context is limited to two reported quarters: the PS ratio has fallen from 125,511x at Q1 2026 to 76,219x at Q2 2026, and the PB ratio has moved from 10.28x to 3.08x, both reflecting the collapse in share price rather than fundamental improvement. The stock is therefore near the bottom of its short public history on every price-based measure, which could represent genuine value if the contracted pipeline materializes, but with gross margins still negative and cash burn accelerating, the market is currently pricing skepticism about execution rather than optimism.
PE
-108.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
20.6x
Industry PE ~20.6x*
EV/EBITDA
-153.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute because the company is effectively pre-commercial. Q2 2026 revenue of $113,000 produced a gross profit of -$537,000 and a gross margin of -3.91%, meaning unit economics are negative before overhead, while SG&A of $28.92 million and net other expenses of $27.17 million drove a net loss of -$59.53 million versus -$35.26 million in Q1. Free cash flow deteriorated to -$261.22 million in Q2 from -$181.83 million in Q1 on capex of -$226.49 million, and with roughly $443 million burned in H1, the $2.106 billion cash balance is a finite runway that makes dilution a permanent feature of the equity story. Revenue concentration in a handful of long-term PPAs and dependence on continued capacity additions mean any project delay or offtake renegotiation hits the entire thesis.
Market and competitive risks center on valuation compression and sentiment. Trailing multiples are unusable (PE -108, EV/EBITDA -153.45, PB -31.06), so the stock trades on forward sales of roughly 9.8x — a premium to regulated renewable developers that assumes flawless execution of a multi-hundred-fold revenue ramp. The -81.67% drawdown, a +26.09% single-day move, and a 2.84 short ratio describe a high-volatility, heavily shorted name exposed to gap risk in both directions, and relative strength of -50.60% over three months versus SPY's -2.32% shows severe sector rotation out of pre-revenue energy transition names. Analyst anchoring is itself a risk: targets clustered at $34.07 average with a $16-$51 range are likely to be cut if the next print disappoints, which would remove the main support for the bull case.
In a worst-case scenario, the next quarterly report shows revenue still near zero, the revenue ramp slips, and the company announces another equity raise into a falling stock, forcing analysts to mark targets down toward the $16 low or below. A decisive break of the $7.64 52-week low would signal fresh distribution and likely drag the shares toward the $7.79-$8.25 congestion zone or lower, implying a loss of roughly -33% from the current $11.38 to the 52-week low, and a retest of the November 5 capitulation level near $7.79 would be about -32%. In a more severe re-rating where the IPO cohort de-rates further, the drawdown from the $42.65 peak (-81.67%) shows how far this name can fall when sentiment turns.
FAQ
The most severe risk is financial: the company is pre-commercial with a -3.91% gross margin and Q2 free cash flow of -$261.22 million versus -$181.83 million in Q1, meaning roughly $443 million burned in H1 against a $2.106 billion cash balance that must be replenished through dilution. Second is execution and revenue-concentration risk — revenue of $113,000 in Q2 depends on a handful of long-term PPAs, so any project delay or offtake renegotiation hits the entire thesis and leaves the ~9.8x forward sales multiple unsupported. Third is market and sentiment risk: the stock has a -81.67% max drawdown, a 2.84 short ratio, a +26.09% single-day move, and relative strength of -50.60% versus the S&P over three months, all of which describe severe sector rotation out of pre-revenue energy transition names and gap risk in both directions. Fourth is analyst-anchoring risk — the $34.07 average target and unanimous strong_buy rating look stale, and a disappointing print could trigger target cuts that remove the main support for the bull case.
The scenario framework assigns a 50% probability to the base case of $16.00-$22.00, a 25% probability to the bull case of $34.00-$51.00, and a 25% probability to the bear case of $7.64-$11.00. The base case is most likely: revenue ramps gradually rather than in a step function, gross margin stays negative through 2027, at least one more capital raise dilutes equity, and analysts mark targets down from the stale $34.07 average toward the $16.00 low, leaving the stock in the mid-teens. The bull case requires a step-function revenue print toward the ~$777.7 million consensus with gross margin turning positive, plus a short squeeze extension beyond the November 9 session. The bear case requires revenue to stay near zero, a dilutive raise below $10, and a decisive break of the $7.64 52-week low. The key assumption behind the base case is that the contracted PPA pipeline converts into visible capacity additions before the next financing.
The answer depends entirely on which lens you use, and the trailing metrics are unusable. Trailing PE of -108, EV/EBITDA of -153.45, PB of -31.06, and PS of 55,479x are all sign or near-zero-denominator artifacts of a company with $113,000 of quarterly revenue and negative earnings. The only defensible framework is forward sales: a $7.66 billion market cap against ~$777.7 million of consensus revenue implies roughly 9.8x forward sales, a premium to regulated renewable utilities but not extreme for a technology-differentiated geothermal platform with contracted offtake. Relative to its own short public history the stock is at the bottom — PS has fallen from 125,511x at Q1 to 76,219x at Q2 and PB from 10.28x to 3.08x, both driven by the price collapse rather than fundamental improvement. The market is therefore pricing skepticism about execution, not optimism; the stock is cheap versus analyst targets but rich versus what current fundamentals justify, making it fairly-to-richly valued on today's numbers and only undervalued if the revenue ramp materializes.
From a pure risk/reward standpoint, FRVO offers an asymmetric but highly uncertain payoff. The unanimous strong_buy consensus (15 Buys, 0 Holds, 0 Sells) and $34.07 average target imply roughly +199% upside, and even the $16.00 low target implies about +41%, while the realistic downside to the $7.64 52-week low is roughly -33%. That math looks attractive on paper, but the targets appear anchored to pre-collapse prices and the fundamentals do not yet support them: Q2 2026 revenue was $113,000, gross margin was -3.91%, and H1 free cash burn was roughly $443 million. The biggest downside risk is a dilutive capital raise into a falling stock that forces estimate cuts and a retest of the lows. It is a reasonable speculative buy only for investors who can tolerate a -33% or worse drawdown, size the position small, and hold through at least one more capital raise — not for conservative or income-oriented portfolios.
FRVO is structurally a long-term holding but trades like a short-term instrument, which is an uncomfortable combination. The business is early-stage — listed in May 2026, revenue of $113,000 in Q2, negative gross margin, and a buildout funded by a $2.106 billion cash pile that must last through 2027 — so the contracted cash flow ramp that justifies the ~9.8x forward sales multiple will take years, not quarters, to appear. At the same time, the -81.67% max drawdown, +26.09% single-day move, 2.84 short ratio, and -50.60% three-month relative strength versus the S&P mean the price path will be violently volatile, with no dividend (0% yield) to cushion the wait. A concrete minimum holding period of 18-24 months is appropriate, spanning at least two more quarterly reports and one likely capital raise, and position sizes should assume gap risk in both directions. Short-term traders could trade the $7.64-$14.46 range, but that is momentum speculation, not investment.